LEIDEN, NETHERLANDS -- (MARKET WIRE) -- March 29, 2007 -- Biotech company Pharming Group NV (“Pharming” or “the Company”) (Euronext: PHARM) today announced adjustments in its Board of Management (BOM), as well as key appointments in the area of commercial development.
